about
A novel transposon construct expressing PhoA with potential for studying protein expression and translocation in Mycoplasma gallisepticum.Homologue of macrophage-activating lipoprotein in Mycoplasma gallisepticum is not essential for growth and pathogenicity in tracheal organ culturesEvaluation of the Capacity of PCR and High-Resolution Melt Curve Analysis for Identification of Mixed Infection with Mycoplasma gallisepticum Strains.Evaluation of an IgG Enzyme-Linked Immunosorbent Assay as a Serological Assay for Detection of Mycoplasma bovis Infection in Feedlot CattleDevelopment of a recombinant protein-based enzyme-linked immunosorbent assay for diagnosis of Mycoplasma bovis infection in cattle.The oppD Gene and Putative Peptidase Genes May Be Required for Virulence in Mycoplasma gallisepticum.Immune responses to vaccination and infection with Mycoplasma gallisepticum in turkeys.Genetic diversity of Mycoplasma arginini isolates based on multilocus sequence typing.Development of a Mycoplasma gallisepticum infection model in turkeys.A novel mechanism for control of antigenic variation in the haemagglutinin gene family of mycoplasma synoviae.Development and immunogenicity of recombinant GapA(+) Mycoplasma gallisepticum vaccine strain ts-11 expressing infectious bronchitis virus-S1 glycoprotein and chicken interleukin-6.MalF is essential for persistence of Mycoplasma gallisepticum in vivo.Effect of differing +2 amino acids on export of a heterologous PhoA lipoprotein in Mycoplasma gallisepticum.GapA+ Mycoplasma gallisepticum ts-11 has improved vaccine characteristics.Histochemical and morphometric characterization of broncho-pneumonia in calves caused by infection with Mycoplasma bovisDevelopment and immunogenicity of recombinant Mycoplasma gallisepticum vaccine strain ts-11 expressing chicken IFN-γ
P50
Q34329524-F6D14DF4-195E-46E4-A192-47916BECE324Q34891388-485D6966-BED3-4457-89C7-21FE3C33E4CFQ35630584-03815681-35B3-4A0B-B1D3-CC8A1274F900Q36834787-F968933F-BE5B-4C4F-9A85-D3B3F59FEF6DQ37545027-F27100CB-F450-4E46-B3C5-3E39908E8784Q40276586-A57E1CD3-AF95-4BAC-9972-F01D46C40B1DQ40277467-AFB31740-43BC-4744-BFFE-E9A6CA9B0B90Q41058056-AE5A90ED-CF87-4E25-9831-3C53FF6516F3Q41645132-971F286C-21AE-4CD9-A51B-231D68A2DFCBQ42619958-01E95FE1-08E8-4707-944C-E957BC8E330FQ45368733-E78D0E7D-4F11-4219-85D9-9A1F383B1A9BQ51009466-DC4C034E-F0B0-49FF-AF7E-FD9C6AA48625Q51689542-E1A408CF-3FEB-4479-814E-7DE921265EFAQ53852229-1AC00B9B-0F55-42A9-B2F0-AFDCFA730C55Q61161322-C136E2CF-9363-4906-A1D1-63C020EAA37EQ61161324-CBCB12B7-3D65-4118-9183-9DD53D085307
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Kanci
@ast
Anna Kanci
@en
Anna Kanci
@es
Anna Kanci
@nl
type
label
Anna Kanci
@ast
Anna Kanci
@en
Anna Kanci
@es
Anna Kanci
@nl
prefLabel
Anna Kanci
@ast
Anna Kanci
@en
Anna Kanci
@es
Anna Kanci
@nl
P106
P1153
6506802988
P21
P31
P496
0000-0003-0110-1594